Username Password
S&P 500: 1,317.45 Change: +0.03%
BoscoSantini
BoscoSantini
P&P Score: 81.70
Stats
BoscoSantini IS BEATING THE MARKET TODAY
Points: 8.90 (+0.00)
Accuracy: 40.00%
Annual Return: 6.48% 
(11.72% since 8/6/10)
Average Pick Score: 4.45
About Me
Real name BoscoSantini
Email rr4ever@bellsouth.net
Favorites
BoscoSantini has no favorites
Groups
BoscoSantini has no groups
Highlighted Picks
Most Recent  08/05/10
SELL    APOL   $33.08
APOLLO GROUP INC.   +2.00%
The entire "for profit" education system is going to get slammed by congress - sooner than later
Most Successful  08/05/10
SELL    APOL   $33.08
APOLLO GROUP INC.   +39.79%
The entire "for profit" education system is going to get slammed by congress - s…more
Least Successful  08/05/10
BUY    AZN   $41.19
ASTRAZENECA PLC ADS   -37.80%
Solid pharma company with great pipeline and dividend. It pays to just hold it.
Recent Posts
Most Recent Blog Post
BoscoSantini has no blog posts
Most Recent Comments

BoscoSantini has no recent comments

Picks

Open
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
08/05/2010 APOL Rating: 2 SELL One to Three Months $42.83 $33.08
(+2.00%)
- -22.76% +17.02% +39.79 view
08/05/2010 AZN Rating: 3 BUY Three Plus Years $51.99 $41.19
(-0.05%)
- -20.78% +17.02% -37.80 view
08/05/2010 GOOG Rating: 2 BUY Three Plus Years $508.10 $590.01
(-2.12%)
- +16.12% +17.02% -0.90 view
08/05/2010 VMW Rating: 2 BUY Six Months to a Year $80.88 $93.98
(-1.84%)
- +16.20% +17.02% -0.83 view
08/05/2010 AMLN Rating: 2 BUY Three to Six Months $19.96 $27.75
(+8.59%)
- +39.00% +17.02% +21.98 view
Closed
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
All
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
08/05/2010 APOL Rating: 2 SELL One to Three Months $42.83 $33.08
(+2.00%)
- -22.76% +17.02% +39.79 view
08/05/2010 AZN Rating: 3 BUY Three Plus Years $51.99 $41.19
(-0.05%)
- -20.78% +17.02% -37.80 view
08/05/2010 GOOG Rating: 2 BUY Three Plus Years $508.10 $590.01
(-2.12%)
- +16.12% +17.02% -0.90 view
08/05/2010 VMW Rating: 2 BUY Six Months to a Year $80.88 $93.98
(-1.84%)
- +16.20% +17.02% -0.83 view
08/05/2010 AMLN Rating: 2 BUY Three to Six Months $19.96 $27.75
(+8.59%)
- +39.00% +17.02% +21.98 view
Commentary
SELL: APOLLO GROUP INC. (APOL) Rating: 2
Start Price: $42.83
Points: +39.79
Created: 08/05/2010
The entire "for profit" education system is going to get slammed by congress - sooner than later

Comments: 0 | Comment

Recs:
 
BUY: ASTRAZENECA PLC ADS (AZN) Rating: 3
Start Price: $51.99
Points: -37.80
Created: 08/05/2010
Solid pharma company with great pipeline and dividend. It pays to just hold it.

Comments: 0 | Comment

Recs:
 
BUY: GOOGLE INC. (GOOG) Rating: 2
Start Price: $508.10
Points: -0.90
Created: 08/05/2010
GOOG has been a touch wobbly with its market strategy but will quickly right itself. GOOG *is* the Internet and its entry into "communications" with Android cannot be discounted. GOOG is a long term hold

Comments: 0 | Comment

Recs:
 
BUY: VMWARE INC. (VMW) Rating: 2
Start Price: $80.88
Points: -0.83
Created: 08/05/2010
This is a long term hold for me. Although most of VMW is owned by EMC it will perform well . VMW is at the "heart" of Cloud Computing. Unfortunately for most, Cloud Computing is poorly understood but will prove to be "The Next Big Thing"

Comments: 0 | Comment

Recs:
 
BUY: AMYLIN PHARMACEUTICALS INC. (AMLN) Rating: 2
Start Price: $19.96
Points: +21.98
Created: 08/05/2010
Once/week dosing of the currently selling and highly effective BID diabetes drug Exenatide (Byetta) is awaiting 22 Oct 2010 PDUFA date. Only question mark is the ability of management to market the drug. Management has displayed extreme ineptness in the past. Carl Icahn is a major holder.

Comments: 0 | Comment

Recs:
 
Sponsored Links